---
schema_version: "secwatch.filing_event.v1"
accession: "0001628908-22-000138"
form_type: "8-K"
ticker: "EVH"
cik: "0001628908"
company_name: "Evolent Health, Inc."
filed_at: "2022-11-02T23:59:59+00:00"
generated_at: "2026-06-22T14:11:36.376154+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Evolent Health Q3 2022 revenue up 58.5% to $352.6M; net income $2.1M

## Summary
- Revenue of $352.6M, +58.5% YoY; net income $2.1M (0.6% margin).
- Adjusted EBITDA of $28.1M (8.0% margin), vs prior-year loss.
- Total lives on platform 19.5M; EHS 2.1M, Clinical Solutions 17.4M.
- Signed 3 new operating partnerships, including Molina Healthcare expansion and WA ACO for 2023 MSSP.
- Dan McCarthy promoted to President; Kali Beyah appointed Chief People and Brand Officer.

## SEC filing metadata
- accession: 0001628908-22-000138
- form_type: 8-K
- ticker: EVH
- cik: 0001628908
- company_name: Evolent Health, Inc.
- filed_at: 2022-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628908/000162890822000138/0001628908-22-000138-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628908/000162890822000138/evh-20221102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628908-22-000138
- JSON: https://secwatch.observer/filing/0001628908-22-000138.json
- Plain text: https://secwatch.observer/filing/0001628908-22-000138.txt

## Key facts
- Earnings Releases
  Evolent Health, Inc. reported the quarter ended September 30, 2022 results: revenue $352.6 million, net income $2.1 million.
  - Period: the quarter ended September 30, 2022
  - Revenue: $352.6 million
  - Net income: $2.1 million
  - Result: reported results
  source text: Quarter ended September 30, 2022: • Revenue of $352.6 million, an increase of $130.1 million, or 58.5%, from the three months ended September 30, 2021. • Net income attributable to common shareholders of Evolent Health, Inc. of $2.1 million resulting in a net income margin of 0.6%.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1628908/000162890822000138/0001628908-22-000138-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.